Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 628

1.

Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study.

Kim ST, Hong JY, Lee J, Park JO, Lim HY, Kang WK, Park YS.

Target Oncol. 2019 Dec 9. doi: 10.1007/s11523-019-00691-z. [Epub ahead of print]

PMID:
31820199
2.

Design Optimization for a Microfluidic Crossflow Filtration System Incorporating a Micromixer.

Jung SY, Park JE, Kang TG, Ahn KH.

Micromachines (Basel). 2019 Nov 30;10(12). pii: E836. doi: 10.3390/mi10120836.

3.

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: subgroup analysis of the NAPOLI-1 study.

Bang YJ, Li CP, Lee KH, Chiu CF, Park JO, Shan YS, Kim JS, Chen JS, Shim HJ, Rau KM, Choi HJ, Oh DY, Belanger B, Chen LT.

Cancer Sci. 2019 Dec 1. doi: 10.1111/cas.14264. [Epub ahead of print]

4.

Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial.

Kim ST, Oh SY, Lee J, Kang JH, Lee HW, Lee MA, Sohn BS, Hong JH, Park YS, Park JO, Lim HY.

J Cancer. 2019 Oct 15;10(25):6185-6190. doi: 10.7150/jca.37610. eCollection 2019.

5.

Serum transglutaminase 2 activity as a potential biomarker of disease severity and response to omalizumab in chronic spontaneous urticaria.

Bae Y, Kang SH, Park JO, Park GH, Choi JH.

Allergol Int. 2019 Nov 23. pii: S1323-8930(19)30173-X. doi: 10.1016/j.alit.2019.10.009. [Epub ahead of print] No abstract available.

6.

Multifunctional Nanorobot System for Active Therapeutic Delivery and Synergistic Chemo-photothermal Therapy.

Jin Z, Nguyen KT, Go G, Kang B, Min HK, Kim SJ, Kim Y, Li H, Kim CS, Lee S, Park S, Kim KP, Huh KM, Song J, Park JO, Choi E.

Nano Lett. 2019 Dec 11;19(12):8550-8564. doi: 10.1021/acs.nanolett.9b03051. Epub 2019 Nov 11.

PMID:
31694378
7.

A study of skin characteristics with long-term sleep restriction in Korean women in their 40s.

Jang SI, Lee M, Han J, Kim J, Kim AR, An JS, Park JO, Kim BJ, Kim E.

Skin Res Technol. 2019 Nov 6. doi: 10.1111/srt.12797. [Epub ahead of print]

PMID:
31692145
8.

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.

Bray SM, Lee J, Kim ST, Hur JY, Ebert PJ, Calley JN, Wulur IH, Gopalappa T, Wong SS, Qian HR, Ting JC, Liu J, Willard MD, Novosiadly RD, Park YS, Park JO, Lim HY, Kang WK, Aggarwal A, Kim HC, Reinhard C.

Sci Rep. 2019 Oct 25;9(1):15365. doi: 10.1038/s41598-019-51981-5.

9.

Mantle degassing along strike-slip faults in the Southeastern Korean Peninsula.

Lee H, Kim H, Kagoshima T, Park JO, Takahata N, Sano Y.

Sci Rep. 2019 Oct 25;9(1):15334. doi: 10.1038/s41598-019-51719-3.

10.

Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma.

Ludwig AD, Labadie KP, Seo YD, Hamlin DK, Nguyen HM, Mahadev VM, Yeung RS, Wilbur DS, Park JO.

J Oncol. 2019 Sep 15;2019:4564707. doi: 10.1155/2019/4564707. eCollection 2019.

11.

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.

Hong YS, Kim SY, Lee JS, Nam BH, Kim KP, Kim JE, Park YS, Park JO, Baek JY, Kim TY, Lee KW, Ahn JB, Lim SB, Yu CS, Kim JC, Yun SH, Kim JH, Park JH, Park HC, Jung KH, Kim TW.

J Clin Oncol. 2019 Nov 20;37(33):3111-3123. doi: 10.1200/JCO.19.00016. Epub 2019 Oct 8.

PMID:
31593484
12.

Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.

Yoo GS, Park HC, Yu JI, Choi DH, Cho WK, Park YS, Park JO, Lim HY, Kang WK, Lee WY, Kim HC, Yun SH, Cho YB, Park YA, Song KD, Kim SH, Ha SY.

Cancer Res Treat. 2019 Sep 25. doi: 10.4143/crt.2019.261. [Epub ahead of print]

13.

Clinical Outcomes and the Role of Adjuvant Concurrent Chemoradiation Therapy in D2-resected LN-positive Young Patients (≤45 Years) With Gastric Cancer.

Yu JI, Lim DH, Lee J, Kang WK, Park SH, Park JO, Lim HY, Kim ST, Kim S, Sohn TS, Lee JH, An JY, Choi MG, Bae JM, Kim HS, Ahn S.

Anticancer Res. 2019 Oct;39(10):5811-5820. doi: 10.21873/anticanres.13785.

PMID:
31570486
14.

Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.

Hammel P, Kindler HL, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Joo S, Yoo HK, Patel N, Golan T.

Ann Oncol. 2019 Sep 28. pii: mdz406. doi: 10.1093/annonc/mdz406. [Epub ahead of print]

PMID:
31562758
15.

Near-equilibrium glycolysis supports metabolic homeostasis and energy yield.

Park JO, Tanner LB, Wei MH, Khana DB, Jacobson TB, Zhang Z, Rubin SA, Li SH, Higgins MB, Stevenson DM, Amador-Noguez D, Rabinowitz JD.

Nat Chem Biol. 2019 Oct;15(10):1001-1008. doi: 10.1038/s41589-019-0364-9. Epub 2019 Sep 23.

PMID:
31548693
16.

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.

Yoo C, Im HS, Kim KP, Oh DY, Lee KH, Chon HJ, Kim JH, Kang M, Kim I, Lee GJ, Oh SY, Choi Y, Choi HJ, Kim ST, Park JO, Ryoo BY.

Ther Adv Med Oncol. 2019 Aug 23;11:1758835919871126. doi: 10.1177/1758835919871126. eCollection 2019.

17.

Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study.

Kwon D, Kim B, Shin HC, Kim EJ, Ha SY, Jang KT, Kim ST, Lee J, Kang WK, Park JO, Kim KM.

Transl Oncol. 2019 Nov;12(11):1488-1495. doi: 10.1016/j.tranon.2019.07.017. Epub 2019 Aug 20.

18.

Neutralizing antibody to FGFR2 can act as a selective biomarker and potential therapeutic agent for gastric cancer with FGFR2 amplification.

Kim ST, Lee IK, Rom E, Sirkis R, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim KM, Yayon A, Lee J.

Am J Transl Res. 2019 Jul 15;11(7):4508-4515. eCollection 2019.

19.

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.

Lee J, Kim ST, Kim K, Lee H, Kozarewa I, Mortimer PGS, Odegaard JI, Harrington EA, Lee J, Lee T, Oh SY, Kang JH, Kim JH, Kim Y, Ji JH, Kim YS, Lee KE, Kim J, Sohn TS, An JY, Choi MG, Lee JH, Bae JM, Kim S, Kim JJ, Min YW, Min BH, Kim NKD, Luke S, Kim YH, Hong JY, Park SH, Park JO, Park YS, Lim HY, Talasaz A, Hollingsworth SJ, Kim KM, Kang WK.

Cancer Discov. 2019 Oct;9(10):1388-1405. doi: 10.1158/2159-8290.CD-19-0442. Epub 2019 Jul 17.

PMID:
31315834
20.

A wireless tattooing capsule endoscope using external electromagnetic actuation and chemical reaction pressure.

Hoang MC, Le VH, Kim J, Choi E, Kang B, Park JO, Kim CS.

PLoS One. 2019 Jul 16;14(7):e0219740. doi: 10.1371/journal.pone.0219740. eCollection 2019.

21.

The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinoma.

Yoon SE, Kim JH, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST.

J Cancer. 2019 Jun 2;10(14):3140-3144. doi: 10.7150/jca.30355. eCollection 2019.

22.
23.

LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target.

Lee SJ, Byeon SJ, Lee J, Park SH, Park JO, Park YS, Kang WK, Lim HY, Kim KM, Kim ST.

J Immunother. 2019 Oct;42(8):279-283. doi: 10.1097/CJI.0000000000000283.

PMID:
31219974
24.

Energy budget of Drosophila embryogenesis.

Song Y, Park JO, Tanner L, Nagano Y, Rabinowitz JD, Shvartsman SY.

Curr Biol. 2019 Jun 17;29(12):R566-R567. doi: 10.1016/j.cub.2019.05.025.

PMID:
31211973
25.

The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer.

Yoon SE, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST.

J Cancer. 2019 Mar 3;10(7):1611-1615. doi: 10.7150/jca.29106. eCollection 2019.

26.

A Two-Enzyme Adaptive Unit within Bacterial Folate Metabolism.

Schober AF, Mathis AD, Ingle C, Park JO, Chen L, Rabinowitz JD, Junier I, Rivoire O, Reynolds KA.

Cell Rep. 2019 Jun 11;27(11):3359-3370.e7. doi: 10.1016/j.celrep.2019.05.030.

27.

Indirect Force Control of a Cable-Driven Parallel Robot: Tension Estimation using Artificial Neural Network trained by Force Sensor Measurements.

Piao J, Kim ES, Choi H, Moon CB, Choi E, Park JO, Kim CS.

Sensors (Basel). 2019 Jun 1;19(11). pii: E2520. doi: 10.3390/s19112520.

28.

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL.

N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2.

PMID:
31157963
29.

Transoral endoscopic thyroid surgery in a Korean population.

Park JO, Anuwong A, Kim MR, Sun DI, Kim MS.

Surg Endosc. 2019 Jul;33(7):2104-2113. doi: 10.1007/s00464-018-6481-9. Epub 2019 May 28.

PMID:
31139979
30.

Gasless transoral endoscopic thyroidectomy vestibular approach (gasless TOETVA).

Park JO, Park YJ, Kim MR, Sun DI, Kim MS, Koh YW.

Surg Endosc. 2019 Sep;33(9):3034-3039. doi: 10.1007/s00464-019-06826-7. Epub 2019 May 13.

PMID:
31087173
31.

Risk of Revision Following Total Knee Arthroplasty or High Tibial Osteotomy: A Nationwide Propensity-Score-Matched Study.

Yoon JR, Ko SN, Jung KY, Lee Y, Park JO, Shin YS.

J Bone Joint Surg Am. 2019 May 1;101(9):771-778. doi: 10.2106/JBJS.18.00980.

PMID:
31045664
32.

Transoral endoscopic thyroid surgery using robotic scope holder: Our initial experiences.

Park JO, Kim MR, Park YJ, Kim MS, Sun DI.

J Minim Access Surg. 2019 Apr 24. doi: 10.4103/jmas.JMAS_12_19. [Epub ahead of print]

33.

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.

Eng C, Kim TW, Bendell J, Argilés G, Tebbutt NC, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal NH, Sobrero A, Yan Y, Chang I, Uyei A, Roberts L, Ciardiello F; IMblaze370 Investigators.

Lancet Oncol. 2019 Jun;20(6):849-861. doi: 10.1016/S1470-2045(19)30027-0. Epub 2019 Apr 16. Erratum in: Lancet Oncol. 2019 Jun;20(6):e293.

PMID:
31003911
34.

Correction: Rotating hinge knee versus constrained condylar knee in revision total knee arthroplasty: A meta-analysis.

Yoon JR, Cheong JY, Im JT, Park PS, Park JO, Shin YS.

PLoS One. 2019 Apr 18;14(4):e0216004. doi: 10.1371/journal.pone.0216004. eCollection 2019.

35.

Selective colony area method for heterogeneous patient-derived tumor cell lines in anti-cancer drug screening system.

Cho JH, Kim JS, Kim ST, Hong JY, Park JO, Park YS, Nam DH, Lee DW, Lee J.

PLoS One. 2019 Apr 17;14(4):e0215080. doi: 10.1371/journal.pone.0215080. eCollection 2019.

36.

The Feasibility of a Prototype Thyroidoscope for Gasless Transoral Endoscopic Thyroidectomy: A Preclinical Cadaver Study.

Park JO, Wang SG, Park D, Bae IH, Lee JC, Lee BJ, Shin SC.

J Laparoendosc Adv Surg Tech A. 2019 Jul;29(7):953-957. doi: 10.1089/lap.2019.0107. Epub 2019 Apr 16.

PMID:
30990359
37.

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.

Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):302-310. doi: 10.6004/jnccn.2019.0019.

PMID:
30959462
38.

Achievements, Problems, and Future Direction of the Quality Control Program for Special Periodic Health Examination Agencies in Republic of Korea.

Won YL, Ko KS, Park JO, Choi YJ, Lee H, Sung JM, Lee MY.

Saf Health Work. 2019 Mar;10(1):125-129. doi: 10.1016/j.shaw.2018.11.003. Epub 2018 Dec 1.

39.

Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer.

Seo YD, Jiang X, Sullivan KM, Jalikis FG, Smythe KS, Abbasi A, Vignali M, Park JO, Daniel SK, Pollack SM, Kim TS, Yeung R, Crispe IN, Pierce RH, Robins H, Pillarisetty VG.

Clin Cancer Res. 2019 Jul 1;25(13):3934-3945. doi: 10.1158/1078-0432.CCR-19-0081. Epub 2019 Apr 2.

PMID:
30940657
40.

Staged Mosaic Punching Excision of a Kissing Nevus on the Eyelid.

Cho HJ, Lee W, Jeon MK, Park JO, Yang EJ.

Aesthetic Plast Surg. 2019 Jun;43(3):652-657. doi: 10.1007/s00266-019-01362-0. Epub 2019 Apr 1.

PMID:
30937473
41.

Rotating hinge knee versus constrained condylar knee in revision total knee arthroplasty: A meta-analysis.

Yoon JR, Cheong JY, Im JT, Park PS, Park JO, Shin YS.

PLoS One. 2019 Mar 25;14(3):e0214279. doi: 10.1371/journal.pone.0214279. eCollection 2019. Erratum in: PLoS One. 2019 Apr 18;14(4):e0216004.

42.

Preventable Trauma Death Rate after Establishing a National Trauma System in Korea.

Jung K, Kim I, Park SK, Cho H, Park CY, Yun JH, Kim OH, Park JO, Lee KJ, Hong KJ, Yoon HD, Park JM, Kim S, Sung HK, Choi J, Kim Y.

J Korean Med Sci. 2019 Feb 22;34(8):e65. doi: 10.3346/jkms.2019.34.e65. eCollection 2019 Mar 4.

43.

Bridging genomics and phenomics of gastric carcinoma.

Cho J, Ahn S, Son DS, Kim NK, Lee KW, Kim S, Lee J, Park SH, Park JO, Kang WK, An JY, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kim KM.

Int J Cancer. 2019 Nov 1;145(9):2407-2417. doi: 10.1002/ijc.32228. Epub 2019 Mar 18.

PMID:
30801717
44.

Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial.

Kim ST, Kang JH, Lee J, Lee HW, Oh SY, Jang JS, Lee MA, Sohn BS, Yoon SY, Choi HJ, Hong JH, Kim MJ, Kim S, Park YS, Park JO, Lim HY.

Ann Oncol. 2019 May 1;30(5):788-795. doi: 10.1093/annonc/mdz058.

PMID:
30785198
45.

Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review.

Labadie KP, Schaub SK, Khorsand D, Johnson G, Apisarnthanarax S, Park JO.

World J Hepatol. 2019 Jan 27;11(1):119-126. doi: 10.4254/wjh.v11.i1.119.

46.

Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I Trial.

Kim ST, Lee S, Park M, Park SH, Park JO, Lim HY, Park YS, Kang WK, Gangolli EA, Shin H, Kim KM, Hollingsworth SJ, Mortimer PGS, Lee J.

Transl Oncol. 2019 Apr;12(4):597-601. doi: 10.1016/j.tranon.2018.12.009. Epub 2019 Jan 26.

47.

The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice.

Yoon SE, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST.

Onco Targets Ther. 2018 Dec 24;12:225-231. doi: 10.2147/OTT.S187621. eCollection 2019.

48.

Production of bio-oil from fast pyrolysis of biomass using a pilot-scale circulating fluidized bed reactor and its characterization.

Park JY, Kim JK, Oh CH, Park JW, Kwon EE.

J Environ Manage. 2019 Mar 15;234:138-144. doi: 10.1016/j.jenvman.2018.12.104. Epub 2019 Jan 4.

PMID:
30616185
49.

Curvature-Induced Twist in Homeotropic Nematic Tori.

Ellis PW, Nayani K, McInerney JP, Rocklin DZ, Park JO, Srinivasarao M, Matsumoto EA, Fernandez-Nieves A.

Phys Rev Lett. 2018 Dec 14;121(24):247803. doi: 10.1103/PhysRevLett.121.247803.

PMID:
30608771
50.

Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial.

Kim Y, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH.

J Gastric Cancer. 2018 Dec;18(4):348-355. doi: 10.5230/jgc.2018.18.e34. Epub 2018 Nov 16.

Supplemental Content

Loading ...
Support Center